Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT01891279 · ClinicalTrials.gov registry record · NA
Elemental Formula in Neonates Post Small Bowel Resection: Improved Weaning From Total Parenteral Nutrition?
A NA study, sponsored by The University of Texas Health Science Center, Houston.
- Completed
- Registry status
- NA
- Development phase
- 35
- Enrollment target
NCT01891279 is a NA study that has completed, run by The University of Texas Health Science Center, Houston. The registered enrollment target is 35 participants.
The verdict
NCT01891279, a NA study, has completed, sponsored by The University of Texas Health Science Center, Houston.
- COMPLETED
- Registry status
- NA
- Development phase
- 35 participants
- Enrollment target
Study Summary
In neonates with recent small bowel resection or congenital bowel anomalies (gastroschisis or omphalocele), does an elemental formula as compared to a partially hydrolyzed formula allowed the infant to wean off Total Parenteral Nutrition (TPN) earlier?
Interventions
- OTHER elemental formula Elecare®
- OTHER partially hydrolyzed formula
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 35 participants |
| Start Date | 2011-09-26 |
| Est. Completion | 2013-09-17 |
| Phase | NA |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT01891279
The ClinicalTrials.gov registry entry for NCT01891279 describes a study currently listed as completed, categorized as NA. The registered enrollment target is 35 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is The University of Texas Health Science Center, Houston, which has 732 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 2 interventions - of which elemental formula Elecare® is the first listed.
NCT01891279 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT01891279 about?
NCT01891279 is a clinical study titled "Elemental Formula in Neonates Post Small Bowel Resection: Improved Weaning From Total Parenteral Nutrition?". In neonates with recent small bowel resection or congenital bowel anomalies (gastroschisis or omphalocele), does an elemental formula as compared to a partially hydrolyzed formula allowed the infant to wean off Total Parenteral Nutrition (TPN) earlier?
What is the current status of trial NCT01891279?
This trial is currently completed. It is a NA study. The enrollment target is 35 participants. The study started on 2011-09-26. Estimated completion is 2013-09-17.
What interventions are being tested in trial NCT01891279?
The interventions under investigation include: elemental formula Elecare® (OTHER), partially hydrolyzed formula (OTHER).
Who is sponsoring clinical trial NCT01891279?
This trial is sponsored by The University of Texas Health Science Center, Houston, which has 732 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.